The Growing Role of Specialty Drugs in Employer Benefits Programs - Janet Young

Episode notes

For the past few years, specialty drugs have played a large and growing role in the overall cost of employee healthcare. In this episode, Janet Young, M.D., lead clinical scientist and co-author of Springbuk's 2023 Employee Health Trends Report , describes the factors that are driving the biggest increases and get some tips on what employers can do to keep their costs under control. Catch the full conversation.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Navigating High-Cost Claims: Employer Strategies for Managing Complex Healthcare Cases with Dr. Christine Hale, Chief Medical Officer, US Benefits at GallagherThe Benefits Playbook · on health insurance85 / 100
• Episode 124: Annie Lamont on Healthcare, AI, Epic, Medicaid, and the Future of American MedicineThe Puck: Venture Capital and Beyond · on Specialty drugs79 / 100
• “I quite like the chaos of startups” with Luke Mackey, CEO of Kota.The Renatus Podcast · on health insurance70 / 100
• The Real Reason Industry Giants Win at Affiliate MarketingDigital Marketing Stories · on health insurance52 / 100
• [S2E20] Vincent Catalano: Let’s Not Normalize Medical DebtCLEARly Beneficial Podcast · on health insurance49 / 100
• The 4 Pillars of a Total Rewards StrategyHR Party of One · on health insurance36 / 100

• Moving Beyond Pain: Tackling MSK Conditions with Micro-Wellness57 / 100
• Decoding the Fine Print: How Hi Neo Makes Healthcare Make Sense68 / 100
• Innovating Radiology Access: OneImaging’s Blueprint for Healthcare Savings74 / 100
• Breaking the Silence: Why Menopause Matters in the Workplace77 / 100
• Gut Check: Why GI Conditions Are Skyrocketing in Employer Healthcare Costs